Press release: New scientific reports demonstrate the high accuracy of mariPOC COVID-19 tests in decentralized testing
Nasal sampling and EU RAT list
Press release: ArcDia launches a quick and automated COVID-19 antigen test with superior performance
Press release: Bruker to distribute ArcDia’s mariPOC® products for automated antigen POCT of COVID-19 and other infectious diseases in Central Europe
Press release: ArcDia Ltd’s automated coronavirus point-of-care test CE marked and available
Press Release: ArcDia Ltd reports a breakthrough in the development of an automated coronavirus point-of-care test
Press Release: ArcDia’s products would allow testing of all respiratory tract and COVID-19 patients in Finland
New mariPOC® publication: Evaluation of a Gastrointestinal Pathogen Panel Immunoassay in Stool Testing of Patients with Suspected Clostridioides (Clostridium) difficile Infection.
New mariPOC® publication: Comparison of phenotypic and genotypic diagnosis of acute human bocavirus 1 infection in children.
ArcDia has entered into an exclusive license agreement with Xinhua Healthcare for the commercialisation of ArcDia’s mariPOC® technology in China
New research data shows that influenza antigen testing correlates best with the infectivity period
New test for Flu A
New mariPOC® Gastro test available
The diagnostics of group A streptococcus from pharyngeal swab samples by bacterial culture is challenged by a novel mariPOC point of care test.
The Evolution of Rapid POC Tests for Infectious Disease Diagnostics: An Exclusive SelectScience Interview
New press release
New press release
ArcDia has expanded its distributor and service network to cover 16 countries in Europe and Middle-East, twelve of which have been signed during the last four months. To read the press release, please click here